1. | | No longer recruiting | 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment Conditions: Leukemia; Lymphoma; Multiple Myeloma |
2. | | No longer recruiting | 506U78 in Treating Patients With Lymphoma Conditions: Leukemia; Lymphoma |
3. | | No longer recruiting | 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Conditions: recurrent adult lymphoblastic lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent childhood lymphoblastic lymphoma; ... |
4. | | No longer recruiting | 6-Hydroxymethylacylfulvene in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer Conditions: Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; recurrent non-small cell lung cancer |
5. | | Recruiting | Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia Conditions: B-cell adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ... |
6. | | Not yet recruiting | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease; Non-Hodgkin's Lymphoma; ... |
7. | | No longer recruiting | Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; Waldenstrom's Macroglobulinemia; recurrent grade I follicular small cleaved cell lymphoma; ... |
8. | | Recruiting | Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer |
9. | | No longer recruiting | Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer Conditions: adenocarcinoma of the prostate; recurrent prostate cancer |
10. | | No longer recruiting | Arsenic Trioxide in Treating Patients With Recurrent Bladder or Urinary Tract Cancer Conditions: recurrent urethral cancer; transitional cell carcinoma of the bladder; recurrent bladder cancer; ... |
11. | | No longer recruiting | Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed Conditions: stage I rectal cancer; stage I colon cancer; prevention of colorectal cancer; stage III colon cancer; stage III rectal cancer; stage II colon cancer; ... |
12. | | Recruiting | Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
13. | | Recruiting | Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer |
14. | | Recruiting | Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma Conditions: recurrent adult Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; ... |
15. | | No longer recruiting | Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer |
16. | | No longer recruiting | Capecitabine in Treating Patients With Malignant Mesothelioma Conditions: recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; sarcomatous mesothelioma; ... |
17. | | No longer recruiting | Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer Conditions: stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; large cell lung cancer; ... |
18. | | No longer recruiting | Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery Conditions: Squamous Cell Lung Cancer; stage III non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer |
19. | | No longer recruiting | Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
20. | | Recruiting | Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer Conditions: recurrent breast cancer; stage IV breast cancer |
21. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
22. | | Recruiting | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer Conditions: Esophageal Cancer; Gastric Cancer |
23. | | Recruiting | Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma Conditions: stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ... |
24. | | Recruiting | Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer Conditions: Quality of Life; psychosocial effects/treatment; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
25. | | No longer recruiting | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma; renal granular cell carcinoma |
26. | | No longer recruiting | Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Conditions: stage II colon cancer; stage III colon cancer |
27. | | No longer recruiting | Chemotherapy in Treating Patients with Stage II or Stage III Colon Cancer That Has Been Surgically Removed Conditions: stage III colon cancer; stage II colon cancer |
28. | | No longer recruiting | Chemotherapy in Treating Women With Resected Breast Cancer Following Tamoxifen Therapy Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
29. | | Recruiting | Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Conditions: stage III melanoma; Recurrent Melanoma |
30. | | No longer recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission Conditions: adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ... |
31. | | No longer recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer |
32. | | No longer recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed Conditions: stage III rectal cancer; adenocarcinoma of the rectum; stage II rectal cancer |
33. | | Recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Conditions: stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus |
34. | | Completed | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Conditions: Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; stage IIIA non-small cell lung cancer; ... |
35. | | Completed | Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer Conditions: ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ... |
36. | | Recruiting | Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer |
37. | | Recruiting | Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Condition: adult acute lymphoblastic leukemia in remission |
38. | | No longer recruiting | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer (Pancoast Tumors) Conditions: stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ... |
39. | | No longer recruiting | Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer Conditions: transitional cell carcinoma of the bladder; stage 0 bladder cancer; recurrent bladder cancer |
40. | | Recruiting | Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Conditions: extragonadal germ cell tumor; Testicular Cancer |
41. | | Recruiting | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer |
42. | | Recruiting | Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer |
43. | | No longer recruiting | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer |
44. | | Recruiting | Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
45. | | Completed | Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer Condition: extensive stage small cell lung cancer |
46. | | No longer recruiting | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Conditions: adult diffuse large cell lymphoma; adult immunoblastic large cell lymphoma |
47. | | No longer recruiting | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Condition: limited stage small cell lung cancer |
48. | | Recruiting | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer Conditions: stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas |
49. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma Conditions: Graft Versus Host Disease; stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; ... |
50. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Conditions: recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ... |